Zobrazeno 1 - 10
of 620
pro vyhledávání: '"Ou Bai"'
Autor:
Yuankai Shi, Keshu Zhou, Hui Zhou, Yan Qin, Hongmei Jing, Ying Xiang, Zhao Wang, Zhen Wang, Aimin Zang, Ou Bai, Zhenyu Li, Huilai Zhang, Yongping Song, Jinjin Liang, Min Wei
Publikováno v:
EClinicalMedicine, Vol 73, Iss , Pp 102702- (2024)
Summary: Background: MIL62, a novel glycoengineered type Ⅱ anti-CD20 monoclonal antibody, with a nearly completely afucosylated N-glycans in Fc region, has demonstrated superior activity compared with rituximab and obinutuzumab in vitro and in vivo
Externí odkaz:
https://doaj.org/article/2a3c6df3d77e4c00af3f193cded6e60d
Autor:
Yan Qin, Yongping Song, Dong Wang, Ou Bai, Jifeng Feng, Xiuhua Sun, Lihua Qiu, Jianmin Yang, Yu Yang, Zhao Wang, Jianda Hu, Huaqing Wang, Hang Su, Zhengming Jin, Wenbin Qian, Chuan Jin, Mingzhi Zhang, Ding Yu, Li Liu, Guoan Chen, Yarong Li, Tao Sun, Jie Jin, Huizheng Bao, Xin Du, Hui Zhou, Gan Fu, Yuankai Shi
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-10 (2024)
Abstract HLX01 (HanliKang®) is a rituximab biosimilar that showed bioequivalence to reference rituximab in untreated CD20-positive diffuse large B-cell lymphoma (DLBCL) in the phase 3 HLX01-NHL03 study. Here, we report the 5-year follow-up results f
Externí odkaz:
https://doaj.org/article/7eecafad55844bb3b801aa99db2e8a55
Autor:
Zhaoxia Li, Wei Guo, Yangzhi Zhao, Haotian Wang, Jing Guo, Zhe Li, Bowen Wang, Luming Cao, Jihong Xu, Ken H. Young, Ou Bai
Publikováno v:
Cancer Medicine, Vol 13, Iss 10, Pp n/a-n/a (2024)
Abstract Objective Recent studies have found a high prevalence of hepatitis B virus (HBV) infection in patients with non‐Hodgkin's lymphoma (NHL), especially B‐cell non‐Hodgkin's lymphoma (B‐NHL). However, most studies did not classify it and
Externí odkaz:
https://doaj.org/article/7f1e298d4ee1410bb284d225dab6b355
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
The development of lymphoma is a complex multistep process that integrates numerous experimental findings and clinical data that have not yet yielded a definitive explanation. Studies of oncogenic viruses can help to deepen insight into the pathogene
Externí odkaz:
https://doaj.org/article/ae68177876d94b349b3799801667f2e0
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
Marginal zone lymphoma (MZL) is the second most common subtype of inert B-cell non-Hodgkin’s lymphoma, accounting for 5–15% of non-Hodgkin’s lymphoma cases. Patients with MZL have a long survival period, with a median survival of >10 years, and
Externí odkaz:
https://doaj.org/article/6810a35a74ed4176b9078dc2f834c392
Autor:
Zhumei Zhan, Wei Guo, Xin Wan, Bowen Wang, Jia Li, Haotian Wang, Zhe Li, Yuhua Huang, Ken H. Young, Ou Bai
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
ObjectiveThe development of diffuse large B-cell lymphoma (DLBCL) is closely related to the host infection status. China is a highly endemic area for hepatitis B virus (HBV) infection. It is not clear whether HBV infection has a consistent effect on
Externí odkaz:
https://doaj.org/article/7164c0eb53a346a0a9902330d2797284
Publikováno v:
Discover Oncology, Vol 14, Iss 1, Pp 1-10 (2023)
Abstract To investigate the clinical features, survival, and prognostic factors of patients with double primary malignant neoplasms (DPMNs) comprising non-Hodgkin lymphoma (NHL) and malignant solid tumors. Of the 2352 patients diagnosed with NHL, 105
Externí odkaz:
https://doaj.org/article/e735884fc18d4b0195c661702fd07a2d
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
At present, the treatment of lymphoma has entered the era of precision medicine, and CD30, as a transmembrane protein, has become an important marker to help the diagnosis and formulation of treatment plans for lymphomas. This protein is widely expre
Externí odkaz:
https://doaj.org/article/08eeaec48ee949269c1acfb4f07f6757
Autor:
Xingtong Wang, Wei Guo, Xiaoju Shi, Yujia Chen, Youxi Yu, Beibei Du, Min Tan, Li Tong, Anna Wang, Xianying Yin, Jing Guo, Robert C. Martin, Ou Bai, Yan Li
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 42, Iss 1, Pp 1-17 (2023)
Highlights • Obesity negatively impacted progression-free survival and overall survival in lymphoma patients while an aggressive tumor growth pattern was found in obesity-lymphoma mice. • S1P-S1PR1/S1PR3-YAP signaling mediated lymphomagenesis con
Externí odkaz:
https://doaj.org/article/bdb3aeff498240b0b2b4c8f510739b12
Autor:
Wenjie Xiong, Ying Yu, Chunyan Sun, Juan Du, Zhen Cai, Zanzan Wang, Xinxin Cao, Yuting Yan, Jiawen Chen, Yanshan Huang, Zhongxing Jiang, Huihan Wang, Ting Niu, Guangzhong Yang, Hua Xue, Bingzong Li, Honghui Huang, Zhenling Li, Qinhua Liu, Fei Li, Ou Bai, Min Mao, Rong Fu, Ling Wang, Chunrui Li, Xiaoxia Chu, Lihong Liu, Yujun Dong, Luqun Wang, Jun Luo, Yongqiang Wei, Rui Cui, Lugui Qiu, Jian Li, Shuhua Yi
Publikováno v:
Haematologica, Vol 109, Iss 2 (2023)
Externí odkaz:
https://doaj.org/article/42ba1152e3264ade949f653bf6a4b5a1